Further, in the group receiving additive monocytes, the treatment reduced the infiltration of M2 macrophages expressing CD163, suggesting that TIM-3 may promote the differentiation of protumor myeloid cells in the tumor microenvironment [146]. This evidence concerns the gene HAVCR2 and neoplasm.